Skip to main content
Uptal Patel, MD, Nephrology, Durham, NC, Durham Veterans Affairs Medical Center

UptalDPatelMD

Nephrology • Durham, NC

Acute Renal Failure, Hypertension, Kidney & Pancreas Transplantation

Associate Professor, Medicine, Duke University School of Medicine

Join to view full profile

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Patel's full profile

Already have an account?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Nephrology, 2003 - 2005
  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Pediatric Nephrology, 2001 - 2003
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Internal Medicine/Pediatrics, 1997 - 2001
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1997

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2005 - 2018

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical Research in Nephrology: Trials, Trends, and Tools 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Press Mentions

  • Kidney Disease Rates Have Stabilized in U.S
    Kidney Disease Rates Have Stabilized in U.SNovember 7th, 2015
  • New Strategies for Combatting Chronic Kidney Disease, Other Long-Term Conditions
    New Strategies for Combatting Chronic Kidney Disease, Other Long-Term ConditionsJune 25th, 2015
  • Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
    Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)November 3rd, 2023

Grant Support

  • Barriers To Optimal Cardiovascular Medication Use In Diabetes And Renal DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010

Hospital Affiliations

Dr. Uptal Patel, Dr. Uptal Patel, MD, Dr. U Patel, Dr. Uptal D Patel